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ICP0R is a truncated form of the herpes simplex virus type 1 (HSV-1) transactivator protein ICP0 that is synthesized at
low levels during infection through an alternative splicing mechanism. In transient expression assays, ICP0R has been
shown to inhibit the transactivation function of several HSV-1 regulatory proteins, suggesting that an antiviral strategy which
alters normal ICP0 mRNA splicing and thereby stimulates the synthesis of ICP0R protein may have potential in suppressing
HSV-1 infections. To explore the feasibility of this approach, a recombinant virus was constructed which expressed high
levels of ICP0R instead of ICP0. Surprisingly, overexpression of the ICP0R protein in this virus, HSV-KST, had no detectable
effect on virus replication, since the growth properties of HSV-KST were indistinguishable from those of the ICP0/ICP0R
null mutant dl1403, and HSV-KST was no more efficient than dl1403 at inhibiting the replication of an ICP0-expressing wild-
type virus. The absence of a demonstrable phenotype in HSV-KST was not due to the acquisition of an inactivating mutation
in the gene encoding ICP0R, since copies of the gene rescued from this virus retained full transrepression capability in
transient expression assays. These results indicate that the ability of ICP0R to act as a transrepressor is significantly
reduced if not completely eliminated in the context of a productive HSV-1 infection and suggest that this protein may not
represent an exploitable target for the development of novel antiviral therapies. q 1997 Academic Press
ICP0 (infected cell polypeptide 0) is an immediate early in a manner that is independent of specific promoter
elements (Everett, 1984; Gelman and Silverstein, 1985;polypeptide encoded by herpes simplex virus type 1
Mosca et al., 1987; O’Hare and Hayward, 1985; Ostrove(HSV-1) that represents a key regulatory protein in the
et al., 1987; Quinlan and Knipe, 1985; Sekulovich et al.,life cycle of this pathogen. ICP0 is not absolutely essen-
1988; Shapira et al., 1987). The mechanism by whichtial for replication in cell culture; however, mutant viruses
ICP0 mediates transactivation has not yet been deter-containing deletions of the gene encoding ICP0 do ex-
mined, but is likely to involve interactions with one orhibit an impaired ability to replicate in low multiplicity
more host cell proteins, including a 135-kDa cellular pro-infections, as exemplified by reduced virus yields and
tein of unknown function (Meredith et al., 1995, 1994)inefficient expression of all classes of viral genes (Sacks
and a complex nuclear structure called the ND10 domainand Schaffer, 1987; Stow and Stow, 1986). These defects
(Everett and Maul, 1994; Maul and Everett, 1994; Maulare particularly pronounced in experimental situations
et al., 1993).involving de novo virus production from viral DNA in the
The mRNA encoding ICP0 is spliced, such that its pro-absence of the virion transactivator protein VP16, includ-
tein-coding sequences are contained within three exonsing transfection of naked viral DNA into cells (Cai and
(Fig. 1) (Perry et al., 1986). Splicing of the primary mRNASchaffer, 1989), reactivation from latent infections in tri-
occurs with high efficiency during productive infection,geminal ganglia explant cocultivation experiments (Cai
and translation of this fully processed transcript yields aet al., 1993; Clements and Stow, 1989; Leib et al., 1989),
775-amino-acid polypeptide with an apparent molecularand reactivation from in vitro latency models (Harris et
weight of 110 kDa (Fig. 1). However, alternative splicingal., 1989; Zhu et al., 1990). Consistent with its proposed
of the primary transcript can occur at low frequencies torole in upregulating viral genes during productive infec-
yield a processed mRNA in which the second intron hastion and reactivation from latency, ICP0 has been shown
been retained (Everett et al., 1993). This results in theto behave as a potent transactivator in transfection
synthesis of a novel truncated 41-kDa polypeptide whichassays, where it activates a wide variety of promoters
contains all 241 amino acids encoded by exons 1 and 2
of the ICP0 gene plus an additional 21 amino acids re-
1 To whom correspondence and reprint requests should be ad- sulting from readthrough into the second intron (Fig. 1).
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FIG. 1. Expression of the ICP0 and ICP0R proteins in HSV-1. (A) Organization of the ICP0 gene of HSV-1. A map of the HSV-1 genome is shown
at the top which identifies the long (L) and short (S) components; the inverted repeat sequences a, b, and c; and the location of the two copies of
the ICP0 gene in the b sequences. The primary transcript and the intron–exon structure of the ICP0 gene are shown below. The sequences deleted
from the HSV-KST genome, which included the splice acceptor site of intron 2 and the entire coding sequences of exon3, are indicated at the
bottom. Note that since the latency-associated transcript overlaps these deleted sequences, HSV-KST is technically an ICP0/LAT double mutant.
(B) Generation of the ICP0R protein through alternative splicing of the primary mRNA transcript of the ICP0 gene. The two potential splicing products
of the primary mRNA transcript of the ICP0 gene, their intron–exon structures, and their relative frequencies in HSV-1 infected cells [based on
(Everett et al., 1993)] are shown. Complete splicing of the mRNA yields the full-length protein ICP0, which is encoded by all three exons of the
gene. A failure to splice out intron 2 yields the truncated protein ICP0R, which is encoded by the first two exons of the gene plus a short stretch
of unspliced intron 2 sequence that is rich in glycine codons (‘‘G’’). (C) Forced expression of the ICP0R protein in HSV-KST. The predicted mRNA
transcript and intron–exon structure of the mutated ICP0 gene of HSV-KST are shown. Note that only expression of ICP0R and not ICP0 is possible
in this virus, since splicing of the intron 2-encoded carboxy-terminal sequences of ICP0R are directly prevented by the removal of the splice acceptor
site of intron 2, and the exon 3 coding sequences of ICP0 have been completely deleted from the viral genome.
was therefore designated ICP0R (Weber et al., 1992). et al., 1993). The mechanism by which ICP0R mediates
transrepression in transient expression assays is un-However, like other dominant negative mutants of ICP0
to which it is structurally very similar (Weber and Wig- known; however, the results of a recent mutational analy-
sis indicate that sequences encompassing a RING fingerdahl, 1992), ICP0R is able to promiscuously inhibit trans-
activation by not only ICP0 but also other HSV-1 regula- metal binding motif (Freemont et al., 1991; Lovering et
al., 1993) encode a domain critical for this function (Spatztory proteins such as ICP4 and VP16. It was subsequently
detected in HSV-1-infected cells at levels that were 5% et al., 1996). It is likely that this domain interacts with a
host cell factor(s) which is critical for transactivation byor less than those of the full-length ICP0 protein (Everett
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HSV-1 regulatory proteins, so that transrepression re- tained a mutation that is essentially identical to the one
in pKST, except that it now utilizes the native polyadenyl-sults from the titration or sequestration of this factor by
ICP0R. ation signals of the ICP0 gene rather than those of the
SV40 early transcription unit (Fig. 1). Moreover, the se-The role that ICP0R plays in the HSV-1 life cycle is
unclear, since a mutant virus which expressed ICP0 but quences upstream of the BamHI site in intron 1 of the
ICP0 gene had been intentionally deleted in pKST-BX/SPnot ICP0R was found to exhibit normal replication in cell
culture and normal infections in mice (Everett, 1991; Na- to prevent this plasmid from expressing ICP0R during
marker transfer transfection, which had been previouslytarajan et al., 1991). Although this mutant was demon-
strated to reactivate normally from latency in mouse tri- shown to severely inhibit progeny virus production (We-
ber et al., 1992). However, successful incorporation ofgeminal ganglia explant cocultivation experiments (Na-
tarajan et al., 1991), it has not yet been examined in more pKST-BX/SP into the HSV-1 genome should restore these
upstream sequences and thereby confer the ability torelevant animal models which assess the capability for
reactivation in vivo. Moreover, the inefficiency of the alter- overexpress ICP0R protein.
The ICP0 null mutant dl1403 (Stow and Stow, 1986)native splicing reaction that is required for ICP0R expres-
sion makes it impossible to assess what effect higher (generously provided by R. Everett, MRC Virology Unit,
Glasgow, UK) was chosen for use as the parental virusconcentrations of this protein would have on HSV-1 repli-
cation. This question is of particular relevance from a in marker transfer experiments instead of wild-type HSV-
1, since it was reasoned that any reduction in replicativetherapeutic standpoint, since novel antiviral strategies
have been proposed which involve upregulation of the ability conferred by the overexpression of ICP0R protein
might be minimized if the parental virus was alreadyexpression of this transrepressor protein (Weber et al.,
1992). To address these issues, a recombinant virus was unable to make a functional ICP0 protein. The dl1403
genome contained a deletion of ICP0 sequences be-constructed which contained a deletion that prevented
splicing of the intron 2 sequences from the primary tran- tween the XhoI site of exon 2 and the SalI site of exon3,
while the pKST-BX/SP plasmid contained a deletion be-script of ICP0. This manipulation was designed to force
HSV-1 to synthesize high levels of ICP0R instead of ICP0 tween the Sau3AI site of intron 2 and the SalI site of
exon 3, so that successful marker transfer was predicted(Fig. 1), so that the influence of this protein on virus
replication could be readily addressed. to result in the net acquisition of 0.5 kb of ICP0 se-
quences between the XhoI and Sau3AI sites (Fig. 2A).The source of this deletion was the plasmid pKST,
which had been used in the original characterization of To construct the desired recombinant virus, a mixture of
5 mg of cesium chloride gradient-purified pKST-BX/SPthe ICP0R protein in transfection assay experiments (We-
ber et al., 1992). This construct contained a mutant ICP0 plasmid DNA that had been linearized with PstI and 10
mg of cesium chloride gradient-purified dl1403 genomicgene in which all sequences downstream of the Sau3AI
site of intron 2, including the intron 2 splice acceptor site, DNA was cotransfected into Vero cells using calcium
phosphate precipitation and a 15% glycerol shock asexon 3 coding sequences, and polyadenylation signals of
ICP0, were replaced by the polyadenylation signals of described previously (Weber et al., 1988). DNA from indi-
vidual plaques of the resulting progeny virus were dotthe SV40 early transcription unit. Since this mutation
eliminated splicing of intron 2, the ICP0 gene in pKST blotted onto nylon membranes and probed with the radio-
labeled 0.5-kb XhoI–XbaI fragment of pKST-BX/SP toexpressed ICP0R instead of ICP0 (Weber et al., 1992).
To construct a recombinant HSV-1 which similarly ex- screen for recombinant viruses that had successfully ac-
quired these plasmid sequences. Virus stocks from hy-pressed ICP0R instead of ICP0, the mutation in pKST
was incorporated into the HSV-1 genome through the bridization-positive plaques were then amplified and sub-
jected to further rounds of plaque purification and dotuse of the marker transfer vehicle pKST-BX/SP. pKST-
BX/SP was constructed in two steps: first, the 1.0-kb blot analysis. Three independently constructed versions
of the desired recombinant virus were eventually isolatedBamHI/XbaI fragment of pKST (Weber et al., 1992) was
inserted into the BamHI and XbaI sites of pUC19 to yield and characterized. Since all three possessed properties
that were essentially identical (unpublished observa-plasmid pKST-BX. The 2.2-kb SalI/PstI fragment of
pIGA15 (Gelman and Silverstein, 1985) was then inserted tions), the characterization of only one of these viral re-
combinants, HSV-KST, will be presented in this study.into the SalI and PstI sites of pKST-BX to yield plasmid
pKST-BX/SP. This final construct therefore contained all The incorporation of the deletion in the pKST-BX/SP
plasmid into the genome of HSV-KST was confirmed byof the ICP0 sequences from the BamHI site in intron 1
to the PstI site downstream of the gene, with an internal extensive restriction site mapping and Southern blot
analysis of viral DNA (unpublished observations); twodeletion in which the sequences from the Sau3AI site of
intron 2 to the SalI site mapping immediately upstream examples of this characterization are illustrated in Fig.
2. The BamHI–PstI fragment of the ICP0 gene of wild-of the ICP0 polyadenylation signals were replaced by a
short stretch of polylinker from pKST containing SstI and type HSV-1 (strain 17) is 4.6 kb in size (Fig. 2A). The
corresponding fragment in dl1403 is predicted to be onlyXbaI sites. The ICP0 gene in pKST-BX/SP therefore con-
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FIG. 2. Southern blot analysis of the genome structure of HSV-KST. (A) Restriction map of the ICP0 gene. The restriction map of the ICP0 gene
of wild-type HSV-1 (strain 17) is shown at the top and includes sites for BamHI, PstI, SalI, and SstI. The locations and sizes of the deletions
introduced into the HSV-KST and dl1403 genomes are indicated above the restriction map; note that the sequences deleted in HSV-KST are replaced
by a novel SstI site derived from the multicloning site (MCS) of a plasmid vector. The two restriction fragments that were radiolabeled and used
as probes in Southern blot hybridizations are identified below the restriction map; these include the 1.6-kb SstI/BamHI fragment (‘‘1.6 probe’’) and
the 2.2-kb SalI/PstI fragment (‘‘2.2 probe’’). The locations and sizes of BamHI/PstI and SstI/PstI restriction fragments from each virus that are predicted
to hybridize with the 2.2 and 1.6 probes, respectively, are shown at the bottom. (B) Southern blot analysis of the HSV-1 ICP0 gene. Genomic DNA
of wild-type HSV-1 (strain 17), HSV-KST, and dl1403 was digested with the indicated restriction enzymes, blotted, and hybridized with the indicated
probes. Autoradiography was performed using a Betagen phosphoimager, and the final image was adjusted to allow for subtraction of background
signal. A molecular weight scale (in kb) is included at the left.
2.4 kb, due to the presence of a 2.2-kb deletion in the from HSV-1 (strain 17)-, dl1403-, and HSV-KST-infected
cells with a radiolabeled fragment corresponding to theICP0 gene in this virus. As discussed earlier, the transfer
of the sequences in pKST-BX/SP into the dl1403 genome 5* end of the ICP0 gene confirmed the presence of the
predicted 6.2-kb SstI–PstI, 4.0-kb SstI–PstI, and 2.5-kbshould reduce the size of this deletion by 0.5 kb; thus,
the BamHI–PstI fragment of HSV-KST is predicted to be SstI fragments in these viruses, respectively (Fig. 2B).
Final verification of the structure of the HSV-KST ge-2.9 kb in size (Fig. 2A). Southern blot analysis of BamHI –
PstI-digested DNA from HSV-1 (strain 17)-, dl1403-, and nome was provided by the direct cloning of the ICP0R
gene from viral DNA as a 2.4-kb NotI–XbaI fragment intoHSV-KST-infected cells demonstrated the existence of
the predicted 4.6-, 2.4-, and 2.9-kb fragments, respec- the 3.0-kb vector-containing fragment of pHXT (Weber
and Wigdahl, 1992). The resulting construct was identicaltively (Fig. 2B).
Additional corroboration of the genomic structure of in structure to pKST, so that the properties of this rescued
gene could be directly compared to those of the originalHSV-KST was provided by analysis of SstI–PstI digests
of viral DNA. This pair of restriction enzymes is predicted ICP0R gene in transfection assays. Two independent iso-
lates of this rescued gene, pKST-resc-1 and pKST-resc-to generate a 6.2-kb ICP0 gene-containing fragment in
wild-type HSV-1 (strain 17), but only a 4.0-kb fragment in 2, were characterized extensively by restriction site map-
ping and found to be indistinguishable from pKST (unpub-dl1403, due to the presence of its 2.2-kb deletion (Fig.
2A). The corresponding fragment in HSV-KST would lished observations). This not only provided the definitive
verification of the genomic structure of HSV-KST, but alsoagain be expected to be 0.5 kb larger than that of dl1403,
or 4.5 kb, were it not for the acquisition of a novel SstI demonstrated that a recombinant HSV-1 could be engi-
neered to express the transrepressor protein ICP0R in-site in the second intron of the ICP0 gene from pKST-
BX/SP. This new site splits the 4.5-kb SstI–PstI fragment stead of the transactivator protein ICP0 and still be prop-
agated in cell culture. However, it was still formally possi-into a 2.5-kb SstI fragment and a 2.0-kb SstI–PstI frag-
ment (Fig. 2A). Hybridization of SstI–PstI-digested DNA ble that the ICP0R gene in HSV-KST had acquired an
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TABLE 1
Transrepression Capabilities of ICP0R Genes Rescued from HSV-KST
Plasmids cotransfected CAT activity Transactivation Transactivation
with pTAAT-CATa (units 1 1003)b (fold increase)c (% of pHXT control)d
None 0.77 (0.05) 1.0 (0.1) 0 (1)
p111 / pHXT 6.37 (1.04) 8.3 (1.4) 100 (19)
p111 / pKST 1.05 (0.25) 1.4 (0.3) 5 (4)
p111 / pKST-resc-1 1.09 (0.09) 1.4 (0.1) 6 (2)
p111 / pKST-resc-2 1.15 (0.19) 1.5 (0.3) 7 (3)
a Vero cells were transfected in triplicate with equimolar amounts of the indicated plasmid constructs using Lipofectin reagent (GIBCO-BRL Life
Technologies, Gaithersburg, MD) as described previously (Spatz et al., 1996).
b Cells were lysed 48 hr posttransfection and extracts prepared using a detergent extraction procedure (Weber and Wigdahl, 1992). The extracts
were then analyzed in CAT assays where the n-butyrylated chloramphenicol products were extracted with mixed xylenes and quantified by liquid
scintillation (Weber and Wigdahl, 1992).
c Transactivation of pTAAT-CAT by the ICPO gene in p111 as measured by the fold increase in CAT activity over that of pTAAT-CAT transfected
alone.
d Transactivation of pTAAT-CAT by the ICPO gene in p111 interpolated from a scale where the control transfections of pTAAT-CAT / p111 /
pHXT and pTAAT-CAT alone represent 100 and 0% transactivation, respectively.
inactivating point mutation during earlier passages of the sion-competent phenotype of these plasmids confirmed
that the ICP0R gene which had been incorporated intovirus; this would yield a rescued gene that was indistin-
guishable from pKST by simple restriction site mapping. the HSV-KST genome had not been inactivated by a point
mutation during the construction of this virus and thatMoreover, the previous finding that ICP0R can act as a
potent transrepressor of HSV-1 gene expression (Weber HSV-KST should express a fully functional ICP0R protein.
To confirm that the mutation that was introduced intoet al., 1992) suggested that overexpression of a func-
tional ICP0R protein was likely to have a negative effect the HSV-KST genome did enable this virus to produce
high levels of ICP0R instead of ICP0, extracts from Veroon virus replication, so that faster growing variants of
HSV-KST expressing inactive forms of this polypeptide cells that had been infected for 18 hr with either HSV-
KST or its dl1403 parent or wild-type HSV-1 (strain 17)may very well have arisen during plaque purification of
virus stocks. were examined for the levels of ICP0R protein detectable
by Western blot analysis (Fig. 3A). The blotted lysatesSince it was of interest to ascertain whether the res-
cued ICP0R genes encoded proteins that were indeed were probed with the ICP0 exon 2-specific monoclonal
antibody 11060 (a generous gift from R. Everett, MRCnonfunctional, these plasmids were examined for their
ability to repress ICP0-mediated transactivation in trans- Virology Unit, Glasgow, UK), which had been previously
shown to recognize the ICP0R protein in HSV-1-infectedfection assays. A recently developed transient transre-
pression assay (Spatz et al., 1996) was employed which cells (Everett et al., 1993). Analysis of extracts from cells
that had been infected with HSV-KST revealed specificutilized cotransfection of the reporter plasmid pTAAT-
CAT, which contains the promoter of the HSV-1 immedi- recognition of a prominent 41-kDa protein by the 11060
antibody (Fig. 3A, lane 3). The molecular weight of thisate early gene ICP4 fused to the chloramphenicol acetyl-
transferase (CAT) gene (Weber and Wigdahl, 1992); the species was comparable to that reported previously for
ICP0R in wild-type HSV-1-infected cells (Everett et al.,ICP0R-expressing plasmid pKST (Weber et al., 1992); and
the ICP0-expressing plasmid p111 (Everett, 1987). Con- 1993), and its identity as ICP0R was confirmed by the
absence of this protein in lysates from cells infected withtrol transfections in which the ICP0R null mutant-encod-
ing plasmid pHXT (Weber and Wigdahl, 1992) was substi- dl1403 (Fig. 3A, lane 2).
In contrast, a 110-kDa protein was readily apparent intuted for pKST determined the level of transactivation by
ICP0 that would be expected to occur in the presence lysates from wild-type HSV-1 (strain 17)-infected cells
(Fig. 3A, lane 1) that was not detected in cells infectedof a defective ICP0R protein; an eightfold induction of
the ICP4 promoter in pTAAT-CAT was observed in these with either HSV-KST or dl1403; the identity of this protein
as ICP0 was consistent with the absence of the ICP0control experiments (Table 1). However, this induction
was reduced by 95% in transfections in which p111 was exon 3 coding sequences in the latter two mutants. Inter-
estingly, the dl1403 virus synthesized low levels of a 32-cotransfected with pKST; more importantly, a comparable
inhibition of transactivation was observed when p111 kDa protein which reacted with the 11060 monoclonal
antibody (Fig. 3A, lane 2). Although the existence of suchwas cotransfected with either of the two ICP0R genes
that had been rescued from the HSV-KST genome, pKST- a polypeptide had been predicted in the original charac-
terization of this virus, it had never been detected (Stowresc-1 and pKST-resc-2 (Table 1). Thus, the transrepres-
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FIG. 3. Western blot analysis of ICP0 and ICP0R protein expression in HSV-1-infected cells. Extracts from Vero cells that were infected individually
with wild-type HSV-1 (strain 17), HSV-KST, or dl1403 (A) or with the indicated mixtures of these viruses (B) were prepared, blotted, and probed with
the ICP0 exon 2-specific monoclonal antibody 11060 (Everett et al., 1993) as described previously (Spatz et al., 1996). The multiplicity of infection
employed for each virus is indicated below each lane. A molecular weight scale is included at left. The molecular weights of ICP0 and ICP0R are
110 and 41 kDa, respectively; both are indicated by the arrows between the panels. The group of negatively staining bands of 50–70 kDa molecular
weight corresponds to residual fetal bovine serum proteins (unpublished observations).
and Stow, 1986). This 32-kDa protein is likely to represent combinant overexpressed a functional ICP0R protein, it
was then of interest to determine what effect this hadthe product of the mutated ICP0 gene in dl1403, whose
deletion fuses the first 105 codons of ICP0 to 56 codons on virus replication. Since ICP0R can act as a powerful
repressor of several HSV-1 transactivator proteins inderived from noncoding sequences downstream of the
gene. Consistent with its lack of function in dl1403 infec- transient expression assays (Weber et al., 1992; Weber
and Wigdahl, 1992), it was anticipated that the expres-tions, this 32-kDa protein failed to mediate any detectable
effects on reporter gene expression in transient expres- sion of high levels of this protein during infection would
have a dramatic effect on virus replication. The growthsion assays (unpublished observations).
Although wild-type HSV-1 (strain 17) has been pre- properties of HSV-KST in both high and low multiplicity
infections were therefore examined and compared withviously demonstrated to synthesize low levels of ICP0R
through alternative splicing of the ICP0 mRNA (Everett those of its dl1403 parent and wild-type HSV-1 (strain
17). Vero cells were infected with each virus at a multi-et al., 1993), no ICP0R protein was detected for this virus
in these experiments (Fig. 3A, lane 1). This was because plicity of infection of either 10 or 0.01; after 24 and 48 hr,
respectively, the cells were frozen and thawed, and theonly trace amounts of ICP0R are synthesized when Vero
cells are employed as the host cells for infection (Everett titers of virus in the resulting supernatants were deter-
mined (Table 2).et al., 1993; unpublished observations), and even these
low levels were visible only if the infection was allowed The dl1403 virus produced yields that were just 10-
fold lower than those of wild-type HSV-1 (strain 17) into proceed past 24 hr (unpublished observations). Thus,
the HSV-KST mutant was capable of synthesizing dramat- high multiplicity infections, but 5500-fold lower in low
multiplicity infections (Table 2). These results were repre-ically higher quantities of the ICP0R protein than wild-
type HSV-1 (strain 17). In fact, the level of ICP0R that was sentative of the multiplicity-dependent defect that would
be expected for a virus which is incapable of expressinggenerated during HSV-KST infections was comparable
to that of ICP0 in wild-type HSV-1 (strain 17) infections ICP0 and were comparable to those that have been re-
ported previously for dl1403 and other ICP0 null mutants(Fig. 3A); moreover, the kinetics of expression of these
two proteins by their respective viruses were found to be (Sacks and Schaffer, 1987; Stow and Stow, 1986). Since
it not only fails to synthesize ICP0 but also overexpressesessentially identical (unpublished observations). These
observations demonstrated that the deletion introduced the transrepressor protein ICP0R, it was expected that
the replicative abilities of HSV-KST would be even moreinto HSV-KST had indeed been successful in forcing this
virus to synthesize ICP0R instead of ICP0. impaired than those of dl1403. However, the yields of
these two viruses were virtually indistinguishable (TableOnce it had been demonstrated that the HSV-KST re-
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TABLE 2 cant de novo replication defect compared to wild-type
HSV-1 (strain 17), as evident by the 63% reduction inReplicative Abilities of HSV-KST
the number of infectious centers that it generates per
Yield (PFU/ml)a microgram of DNA (Fig. 4). However, nearly identical
slopes were obtained for the plots of the HSV-KST and
24-hr infection 48-hr infection dl1403 data (59 versus 79 plaques/mg DNA, respectively;
Virus (m.o.i.  10) (m.o.i.  0.01)
Fig. 4). Moreover, no significant differences in plaque
formation were observed between the two viruses atHSV-1 (strain 17) 2.0 1 107 ({2.0 1 106) 2.7 1 107 ({1.1 1 106)
dl1403 1.6 1 106 ({3.0 1 105) 5.0 1 103 ({2.4 1 103) each individual concentration of DNA tested; in contrast,
HSV-KST 2.5 1 106 ({2.1 1 105) 4.6 1 103 ({3.9 1 102) statistically significant differences were apparent be-
tween wild-type HSV-1 (strain 17) and either of the twoa Yield represents the average number of plaque-forming units/ml
mutants for each DNA concentration (P  0.05–0.02).generated in triplicate infections of 1 1 106 Vero cells in 6-well dishes
Thus, de novo virus production in HSV-KST and its dl1403using the indicated multiplicities and lengths of infection.
parent were virtually identical, indicating that overex-
pression of ICP0R during infection had no detectable
effect on virus replication in the absence of VP16 trans-2). In agreement with these results, there were no appar-
ent differences in the efficiency of gene expression be- activation.
The analyses presented above clearly demonstratetween the two viruses, based on Western blot quantifica-
tion of representative immediate early, early, and late that overexpression of ICP0R does not appear to inhibit
the replication of HSV-KST relative to its dl1403 parent.viral proteins synthesized during infection (unpublished
observations). However, it is important to note that neither of these
viruses express the ICP0 protein, whereas high levels ofThe overexpression of ICP0R protein during HSV-KST
infection therefore appeared to have no detectable effect this transactivator are typically produced in a wild-type
HSV-1 infection. The fact that normal HSV-KST replicationon the replication of this virus. This result was particularly
surprising for the yield experiments that had been carried could be observed in a high multiplicity infection (Table
2), which represents conditions where the absence ofout at a high multiplicity of infection, since significantly
elevated levels of ICP0R accumulation had been de- ICP0 has been shown to be of little if any consequence
(Sacks and Schaffer, 1987; Stow and Stow, 1986), wouldtected under these conditions (Fig. 3A). However, defects
involving the ICP0 protein have been shown to be dra- seem to argue that this distinction may not be relevant.
Nevertheless, it is formally possible that ICP0R may bematically more pronounced in de novo virus infections,
that is, infections in which progeny virus is produced able to exert a deleterious effect on virus replication only
if the infection is actively utilizing the ICP0 transactivatorfrom naked DNA in the absence of the virion transactiva-
tor protein VP16 (Cai and Schaffer, 1989). It was therefore protein. To test this hypothesis, mixed infections of wild-
type HSV-1 (strain 17) and either HSV-KST or dl1403 werepossible that the presence of VP16 in the virus yield
determination experiments may have masked an inhibi- performed to determine whether elevated levels of the
ICP0R protein selectively inhibited virus infections intory effect on replication mediated by the ICP0R protein.
The growth properties of HSV-KST were therefore exam- which ICP0 was present.
In these experiments, Vero cells were coinfected withined in de novo virus infections employing transfection
of infectious cesium chloride gradient-purified viral DNA. the wild-type and mutant viruses at varying multiplicities
for 24 hr, at which time the culture supernatants wereVarying amounts of HSV-KST, dl1403, and wild-type HSV-
1 (strain 17) genomic DNA were transfected into Vero collected and lysates prepared from the remaining cells.
The supernatants were used to determine the titers ofcells and overlaid with media containing methylcellulose
to allow plaque formation. After 3 days, the total numbers wild-type progeny virus by selective enumeration of large
plaques (Table 3), whereas the lysates were used inof infectious centers arising from each concentration of
DNA transfected were determined. Western blot analyses to examine the relative concentra-
tions of ICP0 and ICP0R proteins in these infections (Fig.The results obtained were plotted as the number of
plaques per transfection versus concentration of DNA 3B). Two sets of virus mixture strategies were employed
in these experiments. In the first, Vero cells were coin-transfected and subjected to linear regression analysis.
The linear range for each of the three viruses was deter- fected with wild-type HSV-1 (strain 17) and either mutant
at equal multiplicities of infection (10, 2, or 0.1). However,mined to fall between 0.5 and 6 mg of DNA transfected;
within these limits, the data generated lines with very Western blot analyses of lysates of these cells revealed
that the concentration of ICP0 protein in these infectionsgood fit (r  0.93–0.99, P  0.007–0.0003) (Fig. 4). The
slopes of these lines were then used to calculate the was significantly reduced in the presence of a coinfecting
virus, particularly at the higher multiplicities (Fig. 3B,number of plaques generated per microgram of trans-
fected DNA. Just as in infections employing intact virus lanes 1 to 6). This was likely due to the elevated particle
to PFU ratio that has been described for ICP0-deficientparticles, the ICP0 null mutant dl1403 exhibited a signifi-
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FIG. 4. De novo virus production assay. The number of infectious centers that resulted from transfection of the indicated amounts of wild-type
HSV-1 (strain 17), HSV-KST, or dl1403 genomic DNA into Vero cells was plotted. Linear regression analysis was used to calculate the best fit lines
for each set of data, and the slopes of these lines were used to calculate the numbers of plaques generated per microgram of transfected DNA
that are listed for each virus.
mutants such as HSV-KST and dl1403 (Sacks and Schaf- fecting virus; in fact, no statistically significant differ-
ences in wild-type HSV-1 titers were detected for eachfer, 1987; Stow and Stow, 1986): coinfection with equal
PFUs of wild-type HSV-1 and an ICP0 null mutant actually of the seven mixtures of wild-type HSV-1/HSV-KST and
wild-type HSV-1/dl1403 tested (Table 3). Consistent withresults in a much higher particle number (and therefore
mutant ICP0 gene dosage) for the latter virus, leading to these results, coinfection with HSV-KST did not appear
to have any detectable effect on the efficiency of wild-a reduction in the number of genomes capable of ICP0
expression in the infected cell. Thus, a second mixing type HSV-1 gene expression, based on Western blot
quantification of representative immediate early, early,strategy was employed in which the mutant virus infec-
tion was held to a low multiplicity (0.2, which is still a and late viral proteins synthesized during infection (un-
published observations). The only protein whose expres-high particle multiplicity for an ICP0 mutant virus), while
the wild-type HSV-1 infection was carried out at increas- sion was affected by the presence of HSV-KST was ICP0
(Fig. 3B); however, comparable reductions in ICP0 ex-ing multiplicities (0.2, 1, 5, and 20). Western blot analyses
of lysates of these cells indicated that this approach pression were observed in coinfections with dl1403 for
each virus mixture. As discussed earlier, this is likely theachieved a much greater variation in the relative levels
of the ICP0 and ICP0R proteins (Fig. 3B, lanes 7 to 14) result of the high particle to PFU ratios in these viruses
when compared to wild-type HSV-1. Thus, there was noand even resulted in infections where the ICP0 protein
was the predominant species (Fig. 3B, lane 7) or where apparent difference between the effect of HSV-KST or
dl1403 on the replication of wild type HSV-1 (strain 17).the concentrations of the two proteins were equal (Fig.
3B, lane 9). From these results, it can be concluded that the overex-
pression of ICP0R protein not only failed to mediate aPrevious studies have shown that such coinfections
with wild-type HSV-1 and an ICP0 null mutant generally detectable inhibition of HSV-1 infection in the absence
of ICP0, it had no obvious effect in the presence of thisresult in a modest decrease in titer for the former virus
(Sacks and Schaffer, 1987). This is presumably due to protein as well. These experiments formally eliminated
the hypothesis that ICP0R might inhibit HSV-1 gene ex-a reduction in the available ICP0 transactivator protein
caused by the difference in particle to PFU ratio between pression through direct interaction with the ICP0 protein;
however, this possibility was already inconsistent withthe two viruses, as discussed earlier, and is typically
less than a single order of magnitude in size. In agree- the previous demonstration that dominant negative mu-
tants like ICP0R could mediate transrepression in thement with these earlier studies, coinfection with HSV-1
(strain 17) and dl1403 also resulted in a reduction in wild- absence of ICP0 (Weber and Wigdahl, 1992) and with
the failure to detect ICP0–ICP0R interactions through atype virus yield: in six of the seven virus mixtures that
were tested, the titer of wild-type HSV-1 (strain 17) was variety of in vitro binding assays (unpublished observa-
tions).reduced from 57 to 94% in the presence of coinfecting
dl1403 when compared to an infection in the absence of The finding that overexpression of ICP0R did not ap-
pear to mediate any deleterious effect on the replicativethe mutant (Table 3). However, this reduction in yield
was not increased when HSV-KST was used as the coin- abilities of HSV-KST was clearly unexpected, given the
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TABLE 3
Effect of Coinfecting HSV-KST or dl1403 on Wild-Type HSV-1 (Strain 17) Replication
Virus mixture Wild-type HSV-1 progeny titer (PFU/ml)a Percentage of wild-type HSV-1 aloneb
(A) MOIwtHSV-1  10, MOImutant  10
Wild-type HSV-1 alone 3.9 ({0.4) 1 105 100
Wild-type HSV-1 / dl1403 8.7 ({1.7) 1 104 22 ({4)
Wild-type HSV-1 / HSV-KST 5.2 ({0.6) 1 104 13 ({1)
(B) MOIwtHSV-1  2, MOImutant  2
Wild-type HSV-1 alone 1.4 ({0.2) 1 105 100
Wild-type HSV-1 / dl1403 1.1 ({0.1) 1 104 8 ({1)
Wild-type HSV-1 / HSV-KST 8.9 ({3.7) 1 103 6 ({3)
(C) MOIwtHSV-1  0.1, MOImutant  0.1
Wild-type HSV-1 alone 1.1 ({0.3) 1 104 100
Wild-type HSV-1 / dl1403 2.6 ({0.8) 1 103 23 ({7)
Wild-type HSV-1 / HSV-KST 2.1 ({0.1) 1 103 18 ({1)
(D) MOIwtHSV-1  20, MOImutant  0.2
Wild-type HSV-1 alone 1.0 ({0.1) 1 106 100
Wild-type HSV-1 / dl1403 8.6 ({2.2) 1 105 83 ({22)
Wild-type HSV-1 / HSV-KST 1.0 ({0.1) 1 106 98 ({6)
(E) MOIwtHSV-1  5, MOImutant  0.2
Wild-type HSV-1 alone 3.6 ({ 0.3) 1 105 100
Wild-type HSV-1 / dl1403 1.9 ({0.3) 1 105 51 ({8)
Wild-type HSV-1 / HSV-KST 1.5 ({0.1) 1 105 43 ({1)
(F) MOIwtHSV-1  1, MOImutant  0.2
Wild-type HSV-1 alone 1.7 ({0.1) 1 105 100
Wild-type HSV-1 / dl1403 2.7 ({0.1) 1 104 16 ({1)
Wild-type HSV-1 / HSV-KST 2.4 ({0.5) 1 104 14 ({3)
(G) MOIwtHSV-1  0.2, MOImutant  0.2
Wild-type HSV-1 alone 2.9 ({0.5) 1 104 100
Wild-type HSV-1 / dl1403 7.0 ({2.8) 1 103 24 ({10)
Wild-type HSV-1 / HSV-KST 4.1 ({0.5) 1 103 14 ({2)
a Titer of wild-type HSV-1 progeny resulting from 24-hr infections with the indicated mixture of viruses as determined by selective enumeration
of large plaques.
b Titer of wild-type HSV-1 present in coinfection progeny as a percentage of the titer of wild-type HSV-1 in the absence of coinfecting virus.
demonstrated ability of this protein to function as a pow- that functional wild-type ICP0R accumulates to levels that
are significantly lower than those of its transrepression-erful suppressor of viral gene expression in transfection
assays (Weber et al., 1992). The simplest interpretation defective mutants (Spatz et al., 1996). However, the levels
of ICP0R protein synthesized during infection by HSV-of these results is that a fundamental difference exists
between the ICP0R protein generated during HSV-KST KST appear to be even lower still, since quantitative im-
munofluorescence and Western blot analyses have indi-infection and that from a transfected plasmid. The nature
of this distinction is far from apparent, as immunofluores- cated that the amount of ICP0R protein present in HSV-
KST-infected cells could be as much as 40-fold lowercence analysis indicated that ICP0R synthesized by ei-
ther route has an identical localization within the cell, than that of pKST-transfected cells (unpublished observa-
tions). This finding suggests the intriguing possibility thatand additional experiments did not reveal any obvious
differences in the stability or processing of this protein transrepression requires a threshold level of ICP0R pro-
tein and that the ICP0R generated during HSV-KST infec-(unpublished observations). Although it is possible that
infection by HSV-1 could alter the cellular environment tion fails to influence viral gene expression simply be-
cause it accumulates at concentrations that are well be-so as to prevent transrepression by ICP0R, the finding
that transient expression assay results are generally not low this level. This is in fact consistent with the previous
observation that a 20-fold dilution of a plasmid containinginfluenced significantly by the presence of superinfecting
virus (unpublished observations) would argue against an ICP0 dominant negative mutant similar to ICP0R was
found to eliminate transrepression completely (Weber etthis hypothesis.
One potential explanation for the puzzling behavior of al., 1992). Since the deletion engineered into the HSV-
KST genome would be expected to generate the sameviral expressed ICP0R involves the actual level of protein
expressed during infection. Previous studies have indi- level of ICP0R protein that would result if splicing of
intron 2 from the normal ICP0 transcript were to be com-cated that transrepression can be achieved in the pres-
ence of very little ICP0R protein, based on the finding pletely inhibited during infection, then even under condi-
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